A meta-analysis of real-world data shows that nirsevimab significantly reduces RSV-related hospitalizations, ICU admissions, and lower respiratory tract infections in infants, supporting its role in routine immunization programs.
Most Recent Articles
Increased Cardiac Mortality in Massachusetts During the COVID-19 Pandemic: A Population-Based Study
Cardiac deaths in Massachusetts rose significantly during the COVID-19 pandemic, with a marked shift toward deaths at home—underscoring gaps in timely care and the need for more resilient cardiovascular services.
Portfolio Diet Reduces CVD Mortality and Risk Factors in Diverse Populations
Greater adherence to the Portfolio Diet significantly reduces cardiovascular mortality and risk factors, with evidence showing benefits across both older adults and ethnoculturally diverse young populations.
Cardiac Digital Twins: Advancing Personalized Insights into Heart Function and Disease
Researchers created over 3,800 cardiac digital twins to uncover how sex, age, obesity, and lifestyle influence heart function. This technology offers a powerful tool for personalized cardiovascular risk assessment and treatment.
Tracking Early Cardiac Development: Insights from Live Imaging of Mouse Embryos
Live imaging of mouse embryos revealed that early heart cells follow distinct, organized migration paths during development. This offers new insights into cardiac formation and potential strategies for treating congenital heart...